Tipoline vs. semaglutide: Which weight loss injection is more effective?
Share
With the advancement of medical technology, GLP-1 receptor agonists have become breakthrough drugs for obesity management, among which semaglutide has long been considered the most potent weight-loss drug. However, the latest GLP-1/GIP dual agonist , telpotetide, has demonstrated stronger weight-loss effects than semaglutide in clinical trials , becoming a new favorite in the market.
So, which is more effective, telpolide or smegglutide? What are the differences in their weight loss effects, side effects, suitable populations, and prices? This article will combine the latest clinical research data to help you choose the most suitable weight loss plan for yourself.
1. Telborpeptide vs. Smegglutinin: Key Differences
📌 Smegglutinin : A GLP-1 receptor agonist whose main function is to reduce appetite, slow gastric emptying , and help reduce calorie intake.
📌 Telpoeptide : A GLP-1/GIP dual agonist that, in addition to reducing appetite , can also promote fat breakdown, improve insulin sensitivity, and reduce gastrointestinal side effects .
|
Comparison Dimensions |
Telpoeptide |
Smegglutide |
Comparative advantages |
|
Mechanism of action |
GLP-1 + GIP dual agonist |
GLP-1 monoagonal |
Thiopeptide can further promote fat breakdown |
|
Weight loss results ( 72 weeks) |
The average decrease was 22.5%. |
The average decline was 16.9%. |
Thiopeptide is stronger |
|
The proportion of people who lost ≥20% of their body weight |
57% |
36% |
Telborpeptide makes it easier to lose weight significantly. |
|
Gastrointestinal side effects (nausea, vomiting, diarrhea) |
less |
More |
telpoeptide has better tolerability |
|
Improved blood sugar (decreased HbA1c ) |
-2.37% |
-1.86% |
Telpoeptide is more potent and suitable for people with prediabetes. |
|
Price (US market) |
$1,000 - $1,200/ month |
$900 - $1,200/ month |
Similar prices, but telpoeptide is more effective. |
|
Target audience |
Obese individuals, those struggling with weight management, and those with prediabetes |
Obese people and people with mild metabolic disorders |
Telpoeptide has a wider range of applications |
📌 Conclusion : Telborpeptide is superior to Smegglutinin in terms of weight loss effect, metabolic improvement and tolerability, and is suitable for people who want to lose weight to the maximum extent .
2. Weight loss effect comparison: Which drug is faster and more effective?
Multiple clinical trials have compared the weight loss effects of telpolide and smegglutide , with the most important studies being those on SURMOUNT-1 and STEP-1 .
📌 Weight loss after 72 weeks (SURMOUNT-1 vs. STEP-1)
|
Research |
Telpoeptide |
Smegglutide |
|
Weight loss (average) |
22.5% |
16.9% |
|
The proportion of people who lost ≥20% of their body weight |
57% |
36% |
|
Maximum weight loss |
27% |
18% |
📌 Key findings :
✔ On average, telpotetide has a 5.6% higher weight loss effect than smegglutide , meaning that telpotetide results in faster weight loss within the same time frame .
✔ 57% of patients experienced a weight loss of more than 20% , significantly higher than the 36% achieved with smegglutide .
✔ The maximum weight loss is 27% , far exceeding the 18% of smegglutinin .
💡 Conclusion: Telboride is currently the most potent weight loss drug approved by the FDA , with stronger and faster weight loss effects than Smegglutide, making it particularly suitable for people who need to lose a significant amount of weight.
3. Side effects comparison: Which one is better tolerated?
📌 Common side effects include gastrointestinal discomfort (nausea, vomiting, diarrhea), hypoglycemia, dizziness , etc.
|
Side effect categories |
Telboride ( GLP-1/GIP dual agonist) |
Smegglutide ( GLP-1 monoagonal) |
|
nausea |
31% |
44% |
|
Vomit |
18% |
twenty four% |
|
diarrhea |
twenty one% |
30% |
|
constipate |
14% |
17% |
📌 in conclusion :
• The GIP effect of telpolide can reduce the common gastrointestinal side effects of GLP-1 drugs and improve patient tolerance .
• Compared to smegglutinin, telpolide has a lower incidence of nausea, vomiting, and diarrhea, making it easier to use long-term .
💡 Final conclusion: If you are concerned about gastrointestinal discomfort, telpolide is better tolerated and is a more suitable option for long-term use.
4. Telboride vs. Smegglutide: Which drug is more suitable for you?
📌 If your goal is to lose as much weight as possible ( >20% weight loss)
✔ Telpoeptide is a stronger option , with weight loss of up to 27% , far exceeding that of smegglutide ( 18% ).
📌 If you have previously found it difficult to continue using GLP-1 medications due to side effects (nausea, vomiting)
✔ The GIP effect of telpolide can reduce gastrointestinal side effects, improve tolerance , and make it more suitable for long-term use.
📌 If your primary concern is blood sugar control (e.g., if you have diabetes)
✔ Both drugs can effectively lower blood sugar , but telpolide has a greater effect on lowering blood sugar and is more advantageous for patients with prediabetes.
💡 Final conclusion : If your goal is to lose weight faster and more significantly while minimizing side effects, telpolide is currently the best option.
